Adverum Biotechnologies, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Adverum Biotechnologies, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Adverum Biotechnologies, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $120M.
  • Adverum Biotechnologies, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $69K, a 88.6% decline from 2022.
  • Adverum Biotechnologies, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $607K, a 74.7% decline from 2021.
  • Adverum Biotechnologies, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.4M, a 99.3% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $69K -$538K -88.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 $607K -$1.79M -74.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $2.4M -$354M -99.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $356M +$328M +1163% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $28.2M -$41.8M -59.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $69.9M +$53.2M +318% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $16.7M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.